# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001178913-21-003370
Filing Date
2021-11-03
Accepted
2021-11-03 16:06:16
Documents
53
Period of Report
2021-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | form8k.htm iXBRL | 8-K | 33859
2 | EXHIBIT 99.1 | exhibit_99-1.htm | EX-99.1 | 66029
7 |  | exhibit_99-1slide1.jpg | GRAPHIC | 46707
8 |  | exhibit_99-1slide2.jpg | GRAPHIC | 328392
9 |  | exhibit_99-1slide3.jpg | GRAPHIC | 87693
10 |  | exhibit_99-1slide4.jpg | GRAPHIC | 192854
11 |  | exhibit_99-1slide5.jpg | GRAPHIC | 72749
12 |  | exhibit_99-1slide6.jpg | GRAPHIC | 171456
13 |  | exhibit_99-1slide7.jpg | GRAPHIC | 152360
14 |  | exhibit_99-1slide8.jpg | GRAPHIC | 225962
15 |  | exhibit_99-1slide9.jpg | GRAPHIC | 190379
16 |  | exhibit_99-1slide10.jpg | GRAPHIC | 142461
17 |  | exhibit_99-1slide11.jpg | GRAPHIC | 130251
18 |  | exhibit_99-1slide12.jpg | GRAPHIC | 162061
19 |  | exhibit_99-1slide13.jpg | GRAPHIC | 75732
20 |  | exhibit_99-1slide14.jpg | GRAPHIC | 61155
21 |  | exhibit_99-1slide15.jpg | GRAPHIC | 88612
22 |  | exhibit_99-1slide16.jpg | GRAPHIC | 107316
23 |  | exhibit_99-1slide17.jpg | GRAPHIC | 172039
24 |  | exhibit_99-1slide18.jpg | GRAPHIC | 186328
25 |  | exhibit_99-1slide19.jpg | GRAPHIC | 119406
26 |  | exhibit_99-1slide20.jpg | GRAPHIC | 115019
27 |  | exhibit_99-1slide21.jpg | GRAPHIC | 116662
28 |  | exhibit_99-1slide22.jpg | GRAPHIC | 135033
29 |  | exhibit_99-1slide23.jpg | GRAPHIC | 95197
30 |  | exhibit_99-1slide24.jpg | GRAPHIC | 96249
31 |  | exhibit_99-1slide25.jpg | GRAPHIC | 158643
32 |  | exhibit_99-1slide26.jpg | GRAPHIC | 102891
33 |  | exhibit_99-1slide27.jpg | GRAPHIC | 133801
34 |  | exhibit_99-1slide28.jpg | GRAPHIC | 192107
35 |  | exhibit_99-1slide29.jpg | GRAPHIC | 106629
36 |  | exhibit_99-1slide30.jpg | GRAPHIC | 65531
37 |  | exhibit_99-1slide31.jpg | GRAPHIC | 103407
38 |  | exhibit_99-1slide32.jpg | GRAPHIC | 116764
39 |  | exhibit_99-1slide33.jpg | GRAPHIC | 116257
40 |  | exhibit_99-1slide34.jpg | GRAPHIC | 51898
41 |  | exhibit_99-1slide35.jpg | GRAPHIC | 116796
42 |  | exhibit_99-1slide36.jpg | GRAPHIC | 191422
43 |  | exhibit_99-1slide37.jpg | GRAPHIC | 189951
44 |  | exhibit_99-1slide38.jpg | GRAPHIC | 167831
45 |  | exhibit_99-1slide39.jpg | GRAPHIC | 36210
| Complete submission text file | 0001178913-21-003370.txt |  | 7356088

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | cmmb-20211103.xsd | EX-101.SCH | 4701
4 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | cmmb-20211103_def.xml | EX-101.DEF | 18329
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | cmmb-20211103_lab.xml | EX-101.LAB | 28549
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | cmmb-20211103_pre.xml | EX-101.PRE | 20565
46 | EXTRACTED XBRL INSTANCE DOCUMENT | form8k_htm.xml | XML | 6623

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38807 | Film No.: 211375349
SIC: 2834 Pharmaceutical Preparations